Vimarsana
Biggest News Aggregation in the World

Pint Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pint Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pint Pharma Today - Breaking & Trending Today

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ... - Vimarsana News

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ...

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ...

Empaveli is the first treatment for PNH that binds to the complement protein C3. - Vimarsana News

Empaveli is the first treatment for PNH that binds to the complement protein C3.

SÃO PAULO--(BUSINESS WIRE)--Pint Pharma and OrphanDC announced on July 25th that ANVISA, the National Health Surveillance Agency, approved, on July 25th, 2023, the drug EMPAVELI® (pegcetacoplan, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH)). Empaveli is the first treatment for...

BioCryst Pharma Receives Approval Of ORLADEYO From Public Health Institute Of Chile - Vimarsana News

BioCryst Pharma Receives Approval Of ORLADEYO From Public Health Institute Of Chile

BioCryst Pharmaceuticals, Inc. (BCRX) announced Monday that the Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in patients 12 years of age or older.

BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript - Vimarsana News

BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2022.

Source: fool.com
BioCryst Selects Pint Pharma as Commercial Partner for - Vimarsana News

BioCryst Selects Pint Pharma as Commercial Partner for

RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered...